395 Targeting AKT and DNA-PK as a therapeutic strategy in platinum resistant high-grade serous ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

395 Targeting AKT and DNA-PK as a therapeutic strategy in platinum resistant high-grade serous ovarian cancer

Free

Online download statistics by month:

Online download statistics by month: October 2021 to April 2024

	Abstract	Full	Pdf
Oct 2021	46	0	7
Nov 2021	33	0	9
Dec 2021	12	0	0
Jan 2022	31	0	3
Feb 2022	14	0	0
Mar 2022	10	0	2
Apr 2022	10	0	7
May 2022	24	0	7
Jun 2022	8	0	4
Jul 2022	18	0	2
Aug 2022	12	0	5
Sep 2022	16	0	7
Oct 2022	21	0	2
Nov 2022	14	0	1
Dec 2022	34	0	5
Jan 2023	17	0	2
Feb 2023	14	0	1
Mar 2023	18	0	0
Apr 2023	2	0	0
May 2023	8	0	2
Jun 2023	8	0	4
Jul 2023	10	0	9
Aug 2023	7	0	5
Sep 2023	20	0	0
Oct 2023	12	0	0
Nov 2023	34	0	2
Dec 2023	33	0	2
Jan 2024	26	0	0
Feb 2024	18	0	3
Mar 2024	16	0	6
Apr 2024	9	0	3
Total	555	0	100